Fibrate Therapy

Links shared publicly online about this topic

No heart benefit seen with fibrates in diabetics | Reuters

reuters.com — “ATLANTA (Reuters) - Adding a triglyceride-lowering drug to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 14, 2010 at 12:28 pm By:

HealthNews2 Health News Health News

No heart benefit seen with fibrates in diabetics: ATLANTA (Reuters) - Adding a triglyceride lowering ... http://bit.ly/acJpBz #health #news

2 years ago...

UPDATE 1-No heart benefit seen with fibrates in diabetics | Reuters

reuters.com — “* Fibrates fail to cut heart risk when added to statins * Study tests Abbott's TriCor plus statins in diabetics * TriCor cuts risk in those with higher triglycerides (Adds study details, researcherView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 14, 2010 at 12:55 pm By:

HealthyHeart4U low sodium foods Health Business

No heart benefit seen with fibrates in diabetics - Reuters http://bit.ly/cHzprM

2 years ago...

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors " Eur Heart J

eurheartj.oxfordjournals.org — “Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors " Eur Heart JView full resource at eurheartj.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on January 18, 2010 at 11:41 pm By:

mauron M Auron MD Doctor, Pediatrician, Internist, and Physician

What is CETP? - http://bit.ly/7TZZ2I - a main regulator in lipid metabolism - free PDF

2 years ago...

Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes

medicalnewstoday.com — “Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with typView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 2:06 pm By:

mnt_diabetes MNT Diabetes News Health News

Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes http://mnt.to/3yVd #diabetes

2 years ago...

NEJM -- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

content.nejm.org — “Original Article from The New England Journal of Medicine -- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusView full resource at content.nejm.org

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 1:21 am By:

mauron M Auron MD Doctor, Pediatrician, Internist, and Physician

Combination of fibrate and statin is not superior to statin alone in DM2 - http://bit.ly/9gplMk

2 years ago...

NEJM -- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

content.nejm.org — “Original Article from The New England Journal of Medicine -- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusView full resource at content.nejm.org

  • View Related
  • Share

Most Recently Shared on March 14, 2010 at 2:01 pm By:

IJCPeditors IJCP editors Medical Journal

More on ACCORD - no benefits to adding fibrate to statin in diabetes http://content.nejm.org/cgi/content/full/NEJMoa1001282 AW

2 years ago...

MedWire News - Lipidology - Combination therapy effective for treating mixed dyslipidemia in women

medwire-news.md — “MedWire News Study findings suggest that a combination of fibrate and statin therapies should be considered as a treatment option for women with mixed dyslipidemia. MedWire NewsView full resource at medwire-news.md

  • View Related
  • Share

Most Recently Shared on February 3, 2011 at 10:47 am By:

MedWireNews MedWire News Health News

Comment on our story: Combination therapy effective for treating mixed dyslipidemia in women http://tinyurl.com/4ktcxbs #Lipidology

1 year ago...

Long-term mortality in BIP

theheart.org — “The results suggest that the short-term lipid response to fibrate therapy is important in identifying treated patients in whom long-term survival is substantially improved even after termination of active treatment with the drug, according to investigators. (Goldenberg I et al. Arch Intern Med 2009; 169:508-514.)View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on March 10, 2009 at 8:06 pm By:

theheartorg Shelley Wood Cardiology

BIP study: Long-term mortality benefit with bezafibrate related to HDL-cholesterol change http://tinyurl.com/bszazt

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390